Effectiveness of The Milan System for Reporting Salivary Gland Cytology: A 5-Year Retrospective Review

Document Type : Original Research

Authors

1 Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran

2 Department Pathology, School of Medicine Amir Alam Hospital Tehran University of Medical Sciences, Tehran, Iran

3 Department of Pathology, School of Medicine, Maternal, Fetal and Neonatal Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Abstract
Background & Objective: Use of fine needle aspiration cytology (FNAC) in the diagnosis of salivary gland neoplasms is controversial due to the diverse morphologic patterns and overlapping features between benign and malignant lesions. The Milan system has been introduced to report salivary gland cytopathology. The present study aimed to reclassify salivary gland lesions according to the Milan system for reporting salivary gland cytopathology (MSRSGC) to determine the risk of malignancy (ROM) and estimate the diagnostic accuracy of the Milan system.
Methods: In this retrospective cohort study, 136 salivary gland fine needle aspiration cytology samples taken from patients referred to Imam Khomeini and Amir-Aalam Hospital, Tehran, Iran, from 2016 to 2021, were retrieved along with the histopathological follow-up.  Cytology smears were reviewed and reclassified based on MSRSGC. In addition, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were calculated. 
Results: ROM for each category was 26.7% for non-diagnostic, 12.5% for non-neoplastic, 40% for atypia of undetermined significance (AUS), 0 for benign neoplasm, 0 for salivary gland neoplasm with uncertain malignant potential (SUMP), 100% for suspicious for malignancy, and 100% for malignant group. Sensitivity, specificity, PPV, and NPV in differentiating benign from malignant neoplasms based on MSRSGC were 75.9%, 100%, 100%, and 93.8%, respectively. Diagnostic accuracy was calculated as 94.8%.
Conclusion: MSRSGC may be associated with  a high accuracy in differentiation of  benign and malignant salivary gland neoplasms, indicating its potential value as an effective classification system for reporting salivary gland cytology. The ROM for cytological categories except SUMP can be almost similar to that suggested by MSRSGC.

Keywords

Subjects


  1. Galdirs TM, Kappler M, Reich W, Eckert AW. Current aspects of salivary gland tumors - a systematic review of the literature. GMS Interdiscip Plast Reconstr Surg DGPW. 2019;8:Doc12. [DOI:10.3205/iprs000138] [PMID] [PMCID]
  2. Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146(1):51-8. [DOI:10.1002/path.1711460106] [PMID]
  3. Vallonthaiel AG, Kaushal S, Jangir H, Rajendran HK. Application of the Milan System for Risk Stratification and Its Comparison with a Previous Reporting System of Parotid Gland Cytopathology in a Tertiary Care Centre. Acta Cytol. 2018;62(5-6):352-9. [DOI:10.1159/000492051] [PMID]
  4. Karuna V, Gupta P, Rathi M, Grover K, Nigam JS, Verma NJIJoP, et al. Effectuation to Cognize malignancy risk and accuracy of fine needle aspiration cytology in salivary gland using "Milan System for Reporting Salivary Gland Cytopathology": A 2 years retrospective study in academic institution. Indian Journal of Pathology and Microbiology. 2019;62(1):11-6. [DOI:10.4103/IJPM.IJPM_380_18] [PMID]
  5. Wang H, Fundakowski C, Khurana JS, Jhala N. Fine-Needle Aspiration Biopsy of Salivary Gland Lesions. Arch Pathol Lab Med. 2015;139(12):1491-7. [DOI:10.5858/arpa.2015-0222-RA] [PMID]
  6. Goyal S, Sharma S, Diwaker P. Diagnostic role and limitations of FNAC in oral and jaw swellings. Diagn Cytopathol. 2015;43(10):810-8. [DOI:10.1002/dc.23308] [PMID]
  7. Seethala RR, Griffith CC. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Salivary Gland Tumors. Surg Pathol Clin. 2016;9(3):339-52. [DOI:10.1016/j.path.2016.04.002] [PMID]
  8. Pusztaszeri MP, Garcia JJ, Faquin WC. Salivary gland FNA: New markers and new opportunities for improved diagnosis. Cancer Cytopathol. 2016;124(5): 307-16. [DOI:10.1002/cncy.21649] [PMID]
  9. Song SJ, Shafique K, Wong LQ, LiVolsi VA, Montone KT, Baloch ZJC. The utility of the Milan System as a risk stratification tool for salivary gland fine needle aspiration cytology specimens. Cytopathology. 2019;30(1):91-8. [DOI:10.1111/cyt.12642] [PMID]
  10. Savant D, Jin C, Chau K, Hagan T, Chowdhury M, Koppenhafer J, et al. Risk stratification of salivary gland cytology utilizing the Milan system of classification. Diagn Cytopathol. 2019;47(3):172-80. [DOI:10.1002/dc.24063] [PMID]
  11. Rossi ED, Faquin WCJCC. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): an international effort toward improved patient care-when the roots might be inspired by Leonardo da Vinci. Cancer Cytopathology. 2018;126(9):756-66. [DOI:10.1002/cncy.22040] [PMID]
  12. Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DF, et al. The Milan system for reporting salivary gland cytopathology: Springer; 2018. [DOI:10.1007/978-3-319-71285-7]
  13. Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, et al. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey. Cancer Cytopathol. 2017;125(10):757-66. [DOI:10.1002/cncy.21898] [PMID]
  14. Schmidt RL, Hall BJ, Wilson AR, Layfield LJ. A systematic review and meta-analysis of the diagnostic accuracy of fine-needle aspiration cytology for parotid gland lesions. Am J Clin Pathol. 2011;136(1):45-59. [DOI:10.1309/AJCPOIE0CZNAT6SQ] [PMID]
  15. Wei S, Layfield LJ, LiVolsi VA, Montone KT, Baloch ZW. Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: A comprehensive review. Diagn Cytopathol. 2017;45(9):820-7. [DOI:10.1002/dc.23716] [PMID]
  16. Rossi ED, Wong LQ, Bizzarro T, Petrone G, Mule A, Fadda G, et al. The impact of FNAC in the management of salivary gland lesions: Institutional experiences leading to a risk-based classification scheme. Cancer Cytopathol. 2016;124(6):388-96. [DOI:10.1002/cncy.21710] [PMID]
  17. Velez Torres JM, Tjendra Y, Zuo Y, Garcia-Buitrago M, Jorda M, Kerr DA, et al. Application of the Milan System for Reporting Salivary Gland Cytopathology: A Single Institutional Experience of 354 Cases with Cytologic-Histologic Correlation. Acta Cytol. 2022; 66(6):467-74. [DOI:10.1159/000525263] [PMID]
  18. Leite AA, Vargas PA, Dos Santos Silva AR, Galvis MM, de Sa RS, Lopes Pinto CA, et al. Retrospective application of the Milan System for reporting salivary gland cytopathology: A Cancer Center experience. Diagn Cytopathol. 2020;48(9):821-6. [DOI:10.1002/dc.24464] [PMID]
  19. Jaber OI, Shawash SI. Retrospective implementation of the Milan system for reporting salivary gland cytopathology; a review of 5 years in a specialized cancer center. Diagn Cytopathol. 2021;49(2):187-94. [DOI:10.1002/dc.24621] [PMID]
  20. Kala C, Kala S, Khan L. Milan System for Reporting Salivary Gland Cytopathology: An Experience with the Implication for Risk of Malignancy. J Cytol. 2019; 36(3):160-4. [DOI:10.4103/JOC.JOC_165_18] [PMID]
  21. Val-Bernal JF, Martino M, Marcos S, Yllera E, Garcia-Montesinos B. Fine-needle aspiration cytology in the diagnosis of salivary gland lesions. The role of the Milan system for reporting cytopathology. Acta Otorrinolaringol Esp (Engl Ed). 2020;71(6):343-8. [DOI:10.1016/j.otorri.2019.11.007] [PMID]
  22. Rohilla M, Singh P, Rajwanshi A, Gupta N, Srinivasan R, Dey P, et al. Three‐year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification. Cancer Cytopathol. 2017;125(10):767-75. [DOI:10.1002/cncy.21900] [PMID]
  23. Viswanathan K, Sung S, Scognamiglio T, Yang GCH, Siddiqui MT, Rao RA. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience. Cancer Cytopathol. 2018; 126(8):541-51. [DOI:10.1002/cncy.22016] [PMID]
  24. Wu HH, Alruwaii F, Zeng BR, Cramer HM, Lai CR, Hang JF. Application of the Milan System for Reporting Salivary Gland Cytopathology: A Retrospective 12-Year Bi-institutional Study. Am J Clin Pathol. 2019;151(6):613-21. [DOI:10.1093/ajcp/aqz006] [PMID]
  25. Gaikwad VP, Anupriya C, Naik LPJJoC. Milan system for reporting salivary gland cytopathology-An experience from Western Indian Population. Journal of Cytology. 2020;37(2):93. [DOI:10.4103/JOC.JOC_156_19] [PMID] []
  26. Chen YA, Wu CY, Yang CS. Application of the Milan System for Reporting Salivary Gland Cytopathology: A retrospective study in a tertiary institute. Diagn Cytopathol. 2019;47(11):1160-7. [DOI:10.1002/dc.24279] [PMID]
  27. Rezvani G, Yazdani Bioki F, Khatami R, Keramat H, Moadabi A. Reliability of Fine Needle Aspiration Cytology for Salivary Gland Lesions. J Iran Dent Assoc 2015; 27 (1) :31-7.
Volume 20, Issue 1
Winter 2025
Pages 76-83

  • Receive Date 24 January 2024
  • Revise Date 08 February 2024
  • Accept Date 16 March 2025